Rana Zabad

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

Rana Zabad, Luanne M. Metz, Tiona R. Todoruk et al. · Multiple Sclerosis Journal · 2007 · 120 citations

Neurological Disorder, Immunology, Immunotherapy +19

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Bruce Cree, Gary Cutter, Jerry S. Wolinsky et al. · The Lancet Neurology · 2020 · 99 citations · Full text

CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment

Yonghao Cao, Alyssa Nylander, Sriram Ramanan et al. · Neurology · 2016 · 74 citations · Full text

Ocular Disease, Alternative Dosage Regimens, Pharmacotherapy +19

The association of depression with disease course in multiple sclerosis

Rana Zabad, Scott B. Patten, Luanne M. Metz · Neurology · 2005 · 64 citations

Psychiatry, Lifetime History, Mood Symptom +11